Community pharmacist-led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer.

about

Community pharmacist-led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer.

Item

http://www.wikidata.org/entity/Q47107266

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Community pharmacist-led telep ...... with metastatic breast cancer.

@en

Community pharmacist-led telep ...... with metastatic breast cancer.

@nl

type

Item

label

Community pharmacist-led telep ...... with metastatic breast cancer.

@en

Community pharmacist-led telep ...... with metastatic breast cancer.

@nl

prefLabel

Community pharmacist-led telep ...... with metastatic breast cancer.

@en

Community pharmacist-led telep ...... with metastatic breast cancer.

@nl

P1476

Community pharmacist-led telep ...... with metastatic breast cancer

@en

P2093

Chihiro Sakai

http://www.w3.org/2001/XMLSchema#string

Hitomi Teramachi

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Iguchi

http://www.w3.org/2001/XMLSchema#string

Satoko Yajima

http://www.w3.org/2001/XMLSchema#string

Satoshi Yokoyama

http://www.w3.org/2001/XMLSchema#string

Shuji Yamashita

http://www.w3.org/2001/XMLSchema#string

Yoko Ino

http://www.w3.org/2001/XMLSchema#string

P2860

Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice

Everolimus plus exemestane for the treatment of advanced breast cancer: a review of subanalyses from BOLERO-2

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2.

AntiC: A practice tool for the safe use of oral chemotherapeutics by community and hospital pharmacists.

Health state utilities for metastatic breast cancer.

The Nurse-Led Telephone Follow-Up on Medication and Dietary Adherence among Patients after Myocardial Infarction: A Randomized Controlled Clinical Trial.

Guidelines for outpatient cancer care by community pharmacists

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.

Satisfaction with nurse-led telephone follow up for low to intermediate risk prostate cancer patients treated with radical radiotherapy. A comparative study.

P304

362-365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1715163517732088

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

150

http://www.w3.org/2001/XMLSchema#string

P50

Y Noguchi

P577

2017-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29123595

http://www.w3.org/2001/XMLSchema#string

P932

5661674

http://www.w3.org/2001/XMLSchema#string